AR102995A1 - USE OF SIGMA RECEIVER LIGANDS IN OSTEOARTRITIS - Google Patents

USE OF SIGMA RECEIVER LIGANDS IN OSTEOARTRITIS

Info

Publication number
AR102995A1
AR102995A1 ARP150104064A ARP150104064A AR102995A1 AR 102995 A1 AR102995 A1 AR 102995A1 AR P150104064 A ARP150104064 A AR P150104064A AR P150104064 A ARP150104064 A AR P150104064A AR 102995 A1 AR102995 A1 AR 102995A1
Authority
AR
Argentina
Prior art keywords
osteoartritis
sigma receiver
ligands
sigma
receiver ligands
Prior art date
Application number
ARP150104064A
Other languages
Spanish (es)
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of AR102995A1 publication Critical patent/AR102995A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente se refiere a compuestos de fórmula (1) o fórmula (2) con actividad farmacológica contra el receptor sigma, para su uso en el tratamiento o la prevención de la osteoartritis y el dolor debido a la osteoartritis.This refers to compounds of formula (1) or formula (2) with pharmacological activity against the sigma receptor, for use in the treatment or prevention of osteoarthritis and pain due to osteoarthritis.

ARP150104064A 2014-12-15 2015-12-14 USE OF SIGMA RECEIVER LIGANDS IN OSTEOARTRITIS AR102995A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14382519 2014-12-15

Publications (1)

Publication Number Publication Date
AR102995A1 true AR102995A1 (en) 2017-04-05

Family

ID=52146389

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150104064A AR102995A1 (en) 2014-12-15 2015-12-14 USE OF SIGMA RECEIVER LIGANDS IN OSTEOARTRITIS

Country Status (1)

Country Link
AR (1) AR102995A1 (en)

Similar Documents

Publication Publication Date Title
MX2021003840A (en) PRODRUGS OF CARBIDOPA AND L-DOPA AND METHODS OF USE.
CL2017003404A1 (en) Antibacterial compounds
UY36179A (en) DERIVATIVES OF EXENDINA-4 AS SELECTIVE AGONISTS OF THE GLUCAGON RECEIVER
AR102712A1 (en) INSULIN RECEPTOR PARTIAL AGONISTS
DOP2017000078A (en) INDAZOLS REPLACED WITH BENCILO AS INHIBITORS OF BUB1.
NZ732799A (en) Picolinamides with fungicidal activity
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
CL2016001895A1 (en) Compounds
CL2016003074A1 (en) Compounds derived from 2-oxy-2-phenyl-n-5-pyrrolidin-3-ylamino-1,3,4-thiadiazol-2-ylacetamide, pharmaceutical composition gls1 inhibitors and their use to treat cancer.
MX377534B (en) COMPOUNDS FOR USE IN THE TREATMENT OF HYPERINSULINEMIA.
PH12016500356A1 (en) Nsaid and sigma receptor ligand combinations
PH12017500836A1 (en) Transdermal formulations
CL2015002897A1 (en) Bace1 inhibitors
PH12016501095A1 (en) Gabapentinoids and sigma receptor ligands combinations
CR20170376A (en) TREATMENT OF PEDIATRIC PATIENTS WITH MELLITUS DIABETES OF TYPE 2 WITH LIXISENATIDA
PH12017501071B1 (en) Dihydropyrimidin-2-one compounds and medical use thereof
MX2018005987A (en) HETEROCICLICAL COMPOUNDS FOR THE TREATMENT OF DISEASES.
ES2759940T8 (en) 1,3,4-Thiadiazole compounds and their use to treat cancer
PH12017500910A1 (en) Use of sigma receptor ligands in osteoarthritis
MX383313B (en) Substituted quinolinycyclohexylpropanamide compounds and improved methods for their preparation
DK3503853T3 (en) KNEE ORTHOSIS ADAPTED TO LONG-LASTING, SITTING POSITION
CL2015003211A1 (en) Synergistic combination of paracetamol / celecoxib for the treatment of inflammatory pain.
BR112016019893A2 (en) sialylated glycoprotein compositions and their uses
AR102995A1 (en) USE OF SIGMA RECEIVER LIGANDS IN OSTEOARTRITIS

Legal Events

Date Code Title Description
FB Suspension of granting procedure